Lucas Ward
Stock Analyst at Ascendiant Capital
(0.60)
# 3,766
Out of 4,711 analysts
14
Total ratings
28.57%
Success rate
-29.9%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACON Aclarion | Maintains: Buy | $1.5 → $1.3 | $0.12 | +940.83% | 3 | Nov 27, 2024 | |
| LIQT LiqTech International | Maintains: Buy | $5.15 → $3.2 | $1.69 | +89.35% | 3 | Nov 25, 2024 | |
| VVOS Vivos Therapeutics | Reiterates: Buy | $6.6 | $4.98 | +32.53% | 2 | Nov 20, 2024 | |
| HSCS HeartSciences | Reiterates: Buy | $15 | $3.83 | +291.64% | 1 | Sep 23, 2024 | |
| CYTH Cyclo Therapeutics | Maintains: Buy | $2.6 → $0.95 | $0.63 | +50.79% | 2 | Aug 26, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $338 → $270 | $1.49 | +18,020.81% | 2 | Jul 29, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $29 | $1.26 | +2,185.71% | 1 | Oct 2, 2023 |
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $1.5 → $1.3
Current: $0.12
Upside: +940.83%
LiqTech International
Nov 25, 2024
Maintains: Buy
Price Target: $5.15 → $3.2
Current: $1.69
Upside: +89.35%
Vivos Therapeutics
Nov 20, 2024
Reiterates: Buy
Price Target: $6.6
Current: $4.98
Upside: +32.53%
HeartSciences
Sep 23, 2024
Reiterates: Buy
Price Target: $15
Current: $3.83
Upside: +291.64%
Cyclo Therapeutics
Aug 26, 2024
Maintains: Buy
Price Target: $2.6 → $0.95
Current: $0.63
Upside: +50.79%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $338 → $270
Current: $1.49
Upside: +18,020.81%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $29
Current: $1.26
Upside: +2,185.71%